Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants
- PMID: 1644290
- DOI: 10.1101/gad.6.8.1480
Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants
Abstract
The myc family of cellular oncogenes encodes three highly related nuclear phosphoproteins (c-Myc, N-Myc, and L-Myc) that are believed to function as sequence-specific transcription factors capable of regulating genes important in cellular growth and differentiation. Current evidence indicates that Myc family proteins exist as biologically active heterodimeric complexes in association with another helix-loop-helix leucine zipper phosphoprotein, Max. We have investigated the common and unique properties among the Myc family, as well as the physiological role of Max in the regulation of Myc family function. We demonstrate that trans-activation-incompetent mutants of one Myc family member can act in trans to dominantly suppress the cotransformation activities of all three Myc oncoproteins, indicating that the Myc family functions through common genetic elements in its cellular transformation pathways. Employing co-immunoprecipitation with either anti-Myc or anti-Max antibodies, we show that the transfected normal c-Myc, N-Myc, and L-Myc oncoproteins associate with the endogenous Max protein in REF transformants, indicating that the Max interaction represents at least one component common to Myc family function. In addition, we observed a striking reduction in Myc cotransformation activity when a Max expression construct was added to myc/ras co-transfections. We discuss these biological findings in the context of a proposed model for Myc/Max function and regulation in which Max serves as either an obligate partner in the Myc/Max transcriptional complex or as a repressor in the form of a transcriptionally inert Max/Max homodimer capable of occupying Myc/Max-responsive gene targets.
Similar articles
-
Alternative forms of Max as enhancers or suppressors of Myc-ras cotransformation.Science. 1992 Apr 17;256(5055):373-7. doi: 10.1126/science.256.5055.373. Science. 1992. PMID: 1566084
-
Differential effects by Mad and Max on transformation by cellular and viral oncoproteins.Oncogene. 1995 Aug 3;11(3):587-96. Oncogene. 1995. PMID: 7630643
-
Basal levels of max are sufficient for the cotransformation of C3H10T1/2 cells by ras and myc.Exp Cell Res. 1992 Oct;202(2):532-40. doi: 10.1016/0014-4827(92)90108-k. Exp Cell Res. 1992. PMID: 1397104
-
The Max transcription factor network: involvement of Mad in differentiation and an approach to identification of target genes.Cold Spring Harb Symp Quant Biol. 1994;59:109-16. doi: 10.1101/sqb.1994.059.01.014. Cold Spring Harb Symp Quant Biol. 1994. PMID: 7587059 Review.
-
The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.Oncogene. 1999 May 13;18(19):2955-66. doi: 10.1038/sj.onc.1202750. Oncogene. 1999. PMID: 10378692 Review.
Cited by
-
MYC Family Amplification Dictates Sensitivity to BET Bromodomain Protein Inhibitor Mivebresib (ABBV075) in Small-Cell Lung Cancer.Mol Cancer Res. 2024 Aug 2;22(8):689-698. doi: 10.1158/1541-7786.MCR-23-0599. Mol Cancer Res. 2024. PMID: 38747975 Free PMC article.
-
Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma.Mol Cell. 2024 Jan 18;84(2):261-276.e18. doi: 10.1016/j.molcel.2023.12.003. Epub 2024 Jan 3. Mol Cell. 2024. PMID: 38176414
-
Cancer stem cells: a target for overcoming therapeutic resistance and relapse.Cancer Biol Med. 2023 Dec 29;20(12):985-1020. doi: 10.20892/j.issn.2095-3941.2023.0333. Online ahead of print. Cancer Biol Med. 2023. PMID: 38164743 Free PMC article. Review.
-
RNA N6-methyladenosine reader IGF2BP3 interacts with MYCN and facilitates neuroblastoma cell proliferation.Cell Death Discov. 2023 May 8;9(1):151. doi: 10.1038/s41420-023-01449-3. Cell Death Discov. 2023. PMID: 37156775 Free PMC article.
-
Alterations and Co-Occurrence of C-MYC, N-MYC, and L-MYC Expression are Related to Clinical Outcomes in Various Cancers.Int J Stem Cells. 2023 May 30;16(2):215-233. doi: 10.15283/ijsc22188. Epub 2023 Apr 30. Int J Stem Cells. 2023. PMID: 37105559 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases